Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

18,003 recalls, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 20262025202420232022 All years
Cause Sterility / contaminationNitrosamine impurityChemical / undeclaredParticulate / foreign matterLabeling / mix-upcGMP deviationMicrobial contamination All causes
Class I · High risk

Samurai-X

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0905-2016
Class I · High risk

Tiger King

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0904-2016
Class I · High risk

Night Man

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0903-2016
Class I · High risk

Mojo Risen

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0902-2016
Class I · High risk

Man King

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0901-2016
Class I · High risk

Hard Ten Days

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0900-2016
Class I · High risk

Plant Vigra

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0899-2016
Class I · High risk

Germany Niubian

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0897-2016
Class I · High risk

Black Storm

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0896-2016
Class I · High risk

Black Ant King

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0895-2016
Class I · High risk

Bull's Genital

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0891-2016
Class I · High risk

Bull

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0890-2016
Class I · High risk

Weekend Prince

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0888-2016
Class I · High risk

Stree Overlord

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0887-2016
Class I · High risk

Real Skill

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0886-2016
Class I · High risk

Herb Viagra

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0885-2016
Class I · High risk

Black Ant

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0884-2016
Class II · Moderate risk

Guaifenesin DM Cherry liquid

Defective Delivery System: Firm recalled Guaifenesin liquid and Guaifenesin DM liquid due incorrect dose markings on the dosing cups.

Terminated Packaging defect Perrigo Company PLC NDC 49348-828-34 D-0587-2016
Class II · Moderate risk

Guaifenesin Grape liquid 100 mg/5 mL

Defective Delivery System: Firm recalled Guaifenesin liquid and Guaifenesin DM liquid due incorrect dose markings on the dosing cups.

Terminated Packaging defect Perrigo Company PLC NDC 37808-288-26 D-0586-2016

Recalls by year